The nanochemicals industry has generated $5.67 billion revenue in 2021, and it is projected to generate $8.94 billion revenue in 2030, rising at a rate of 5.2% from 2021 to 2030. It is ascribed to the growing demand for nano-chemicals, led by their applications in various sectors, including electronics, semiconductors, cosmetics, and pharmaceuticals.
 |
| To learn more about this report: https://bit.ly/3WozIYR |
These chemicals are massively used to boost the selectivity and biological molecules' potency to kill cancer cells while causing minimal collateral toxicity to non-malignant cells, which boosts the demand for nano chemicals in the pharmaceutical industry.
Additionally, these chemicals are utilized in various sectors such as rubber, electronic, and battery sectors in massive volume, due to their lightweight, non-resistant nature, high-power density and less flame.
Polymer nanochemicals category is projected to experience faster growth, of over 6.2% in the coming years. It is ascribed to their massive usage in the semiconductor and pharmaceutical industries. This polymer is widely used for controlling the release of drugs in the body, due to its size ranging from 1 to 1000 nm. It also provides protection to drugs and other molecules from the biological environment and offers improved therapeutic index and bioavailability of drug molecules.
North America holds the largest industry share. It is ascribed to technological advancements, increasing research and development expenditure, wide network of pharmaceutical and biotechnological companies in the region.
The stalwarts of the industry are:
1- BASF SE
2- Dupont De Nemours Inc.
3- Merck KGaA
4- SABIC
5- Thermo Fisher Scientific Inc.
6- Solvay SA
7- Delair SAS
8- Evonik Industries AG
9- Huntsman International LLC
Therefore, the rising pharmaceutical applications boost the demand for nanochemicals.
